Sponsored by NASA s Office of Advanced Concepts and Technology (OACT), the Commercial Protein Crystal Growth (CPCG) middeck payload on STS-51 is developed by the Center for Macromolecular Crystallography (CMC), a NASA Center for the Commercial Development of Space based at the University of Alabama in Birmingham. This payload will use the CMC-developed Protein Crystallization Facility (PCF) to process interferon alfa-2b(TradeMark) provided by the Schering Plough Research Institute. The PCF uses temperature as the controlling parameter for crystallization of the proteins. The STS-51 Flight, currently planned for launch in July 1993, will be the sixth flight of the PCF; the fifth flight took place on STS-57 as part of the SPACEHAB-01 payload complement in June 1993. The enclosed Mission Operation Report contains a brief description of the CPCG-03 activity on STS-51. Inquiries may be directed to the OACT Flight Programs Division.


    Zugriff

    Zugriff über TIB

    Verfügbarkeit in meiner Bibliothek prüfen


    Exportieren, teilen und zitieren



    Titel :

    Commercial Protein Crystal Growth (CPCG-03) on STS-51


    Erscheinungsdatum :

    1993


    Format / Umfang :

    13 pages


    Medientyp :

    Report


    Format :

    Keine Angabe


    Sprache :

    Englisch




    Protein crystal growth in microgravity: Status and commercial implications

    Moore, Karen M. / Long, Marianna M. / DeLucas, Lawrence J. | American Institute of Physics | 1999


    Protein Crystal Growth in Microgravity: Status and Commercial Implications

    Moore, K. M. / Long, M. M. / DeLucas, L. J. et al. | British Library Conference Proceedings | 1999


    Solution Crystal Growth: Commercial Opportunities

    Sacco, A. / International Astronomical Federation | British Library Conference Proceedings | 1998


    Commercial crystal growth in space

    Wilcox, W.R. | Tema Archiv | 1991